Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 212

1.

Intra-articular delivery of a nanocomplex comprising salmon calcitonin, hyaluronic acid, and chitosan using an equine model of joint inflammation.

Sladek S, Kearney C, Crean D, Brama PAJ, Tajber L, Fawcett K, Labberte MC, Leggett B, Brayden DJ.

Drug Deliv Transl Res. 2018 Oct;8(5):1421-1435. doi: 10.1007/s13346-018-0557-x.

PMID:
29947020
2.

Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study.

Lu C, Chen Y, Zhang B, Chen Y, Bai F, Chen D.

Clin Interv Aging. 2017 Oct 12;12:1717-1723. doi: 10.2147/CIA.S140900. eCollection 2017.

3.

The area postrema (AP) and the parabrachial nucleus (PBN) are important sites for salmon calcitonin (sCT) to decrease evoked phasic dopamine release in the nucleus accumbens (NAc).

Whiting L, McCutcheon JE, Boyle CN, Roitman MF, Lutz TA.

Physiol Behav. 2017 Jul 1;176:9-16. doi: 10.1016/j.physbeh.2017.03.023. Epub 2017 Mar 22.

4.

Nasal osteoma and inhaled salmon calcitonin: Coincidence or consequence?

Peña-Rodríguez ZA, Haro-García M, Benito-Navarro JR.

Acta Otorrinolaringol Esp. 2017 Nov - Dec;68(6):366-368. doi: 10.1016/j.otorri.2016.09.004. Epub 2017 Jan 6. English, Spanish. No abstract available.

5.

A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.

Henriksen K, Byrjalsen I, Andersen JR, Bihlet AR, Russo LA, Alexandersen P, Valter I, Qvist P, Lau E, Riis BJ, Christiansen C, Karsdal MA; SMC021 investigators.

Bone. 2016 Oct;91:122-9. doi: 10.1016/j.bone.2016.07.019. Epub 2016 Jul 25.

PMID:
27462009
6.

[Seizure after salmon calcitonin administration: A case report].

Maison O, Pierre S, Charpiat B, Duplessy F, Vial T.

Therapie. 2016 Oct;71(5):529-531. doi: 10.1016/j.therap.2016.03.002. Epub 2016 May 4. French. No abstract available.

PMID:
27262670
7.

Does salmon calcitonin cause cancer? A review and meta-analysis.

Wells G, Chernoff J, Gilligan JP, Krause DS.

Osteoporos Int. 2016 Jan;27(1):13-9. doi: 10.1007/s00198-015-3339-z. Epub 2015 Oct 5. Review.

8.

Chondroitin-based nanoplexes as peptide delivery systems--Investigations into the self-assembly process, solid-state and extended release characteristics.

Umerska A, Paluch KJ, Santos-Martinez MJ, Medina C, Corrigan OI, Tajber L.

Eur J Pharm Biopharm. 2015 Jun;93:242-53. doi: 10.1016/j.ejpb.2015.04.006. Epub 2015 Apr 20.

PMID:
25907005
9.

Perioperative alendronate, risedronate, calcitonin and indomethacin treatment alters femoral stem fixation and periprosthetic bone mineral density in ovariectomized rats.

Cankaya D, Tabak Y, Ozturk AM, Gunay MC.

J Orthop Sci. 2015 Jul;20(4):728-33. doi: 10.1007/s00776-015-0717-5. Epub 2015 Mar 26.

10.

Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.

Karsdal MA, Byrjalsen I, Alexandersen P, Bihlet A, Andersen JR, Riis BJ, Bay-Jensen AC, Christiansen C; CSMC021C2301/2 investigators.

Osteoarthritis Cartilage. 2015 Apr;23(4):532-43. doi: 10.1016/j.joca.2014.12.019. Epub 2015 Jan 9.

11.

Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.

Rizzoli R, Sigaud A, Azria M, Herrmann FR.

Osteoporos Int. 2015 Jan;26(1):383-93. doi: 10.1007/s00198-014-2937-5. Epub 2014 Oct 22.

PMID:
25566730
12.

Salmon calcitonin in the treatment of elderly women with type 2 diabetes complicated with osteoporosis.

Dexue L, Yueyue Z.

Pak J Pharm Sci. 2014 Nov;27(6 Suppl):2079-81.

PMID:
25410076
13.

Strategic approaches for enhancement of in vivo transbuccal peptide drug delivery in rabbits using iontophoresis and chemical enhancers.

Oh DH, Kim MJ, Jeon SO, Seo JE, Jeong SH, Kang JW, Choi YW, Lee S.

Pharm Res. 2015 Mar;32(3):929-40. doi: 10.1007/s11095-014-1507-z. Epub 2014 Sep 18.

PMID:
25231009
14.

Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer.

Liu P, Yang DQ, Xie F, Zhou B, Liu M.

Genet Mol Res. 2014 Jul 24;13(3):5285-91. doi: 10.4238/2014.July.24.7.

15.

Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial.

Binkley N, Bone H, Gilligan JP, Krause DS.

Osteoporos Int. 2014 Nov;25(11):2649-56. doi: 10.1007/s00198-014-2796-0. Epub 2014 Jul 16.

16.

Native metastable prefibrillar oligomers are the most neurotoxic species among amyloid aggregates.

Diociaiuti M, Macchia G, Paradisi S, Frank C, Camerini S, Chistolini P, Gaudiano MC, Petrucci TC, Malchiodi-Albedi F.

Biochim Biophys Acta. 2014 Sep;1842(9):1622-9. doi: 10.1016/j.bbadis.2014.06.006. Epub 2014 Jun 14.

17.

Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats.

Feigh M, Hjuler ST, Andreassen KV, Gydesen S, Ottosen I, Henriksen JE, Beck-Nielsen H, Christiansen C, Karsdal MA, Henriksen K.

Eur J Pharmacol. 2014 Aug 15;737:91-6. doi: 10.1016/j.ejphar.2014.05.016. Epub 2014 May 22.

PMID:
24858364
19.

Salmon calcitonin use and associated cancer risk.

Overman RA, Borse M, Gourlay ML.

Ann Pharmacother. 2013 Dec;47(12):1675-84. doi: 10.1177/1060028013509233. Epub 2013 Oct 25. Review.

PMID:
24259626
20.

A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.

Gupta V, Hwang BH, Doshi N, Mitragotri S.

J Control Release. 2013 Dec 10;172(2):541-9. doi: 10.1016/j.jconrel.2013.05.002. Epub 2013 May 14.

PMID:
23680288

Supplemental Content

Loading ...
Support Center